FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2980572009> ?p ?o ?g. }

• W2980572009 endingPage "103351" @default.
• W2980572009 startingPage "103351" @default.
• W2980572009 abstract "Allergic disorders are markedly rising in industrialized countries. The identification of compounds that trigger the immunoglobulin E (IgE)-dependent allergic reaction remain the means to improve the quality of life by limiting patient's exposure to critical allergens. Information concerning the treatment and onset of allergic disorders including atopic dermatitis, allergic rhinitis, and bronchial asthma has been provided by the research over the past decade. Recent studies also indicated that allergic inflammation is associated closely with their exacerbation and progression and indeed is the basic pathophysiology of allergic diseases. As a result of immunological and molecular biological studies our understanding of the mechanism of allergic inflammation with regard to therapeutic agents has improved. While much effort has been paid to developing a new anti-allergic agent, the allergic disease has yet to be completely conquered. The more extensive research will allow the development of new therapeutics to combat allergic diseases. Currently, with respect to mechanism of action anti-allergy drugs are classified into five types including histamine H1 antagonists, leukotriene antagonists, Th2 cytokine inhibitors, thromboxane A2 inhibitors and mediator-release inhibitors. The use of two or more anti-allergy agents together is not acknowledged at present, but this will be the subject of research in the future because with different mechanisms of action anti-allergy agents used at the same time will theoretically increase their effects. This review article focuses on anti-allergy agents highlighting their applications, clinical trials and recent advancement on drugs." @default.
• W2980572009 created "2019-10-25" @default.
• W2980572009 creator A5022174387 @default.
• W2980572009 creator A5062764975 @default.
• W2980572009 date "2020-01-01" @default.
• W2980572009 modified "2023-10-17" @default.
• W2980572009 title "Structural and clinical impact of anti-allergy agents: An overview" @default.
• W2980572009 cites W1481041380 @default.
• W2980572009 cites W1482876427 @default.
• W2980572009 cites W1528649080 @default.
• W2980572009 cites W1545240721 @default.
• W2980572009 cites W1587467912 @default.
• W2980572009 cites W1672778500 @default.
• W2980572009 cites W1964793566 @default.
• W2980572009 cites W1966042907 @default.
• W2980572009 cites W1968624262 @default.
• W2980572009 cites W1970243714 @default.
• W2980572009 cites W1970648068 @default.
• W2980572009 cites W1974131709 @default.
• W2980572009 cites W1976073672 @default.
• W2980572009 cites W1977447670 @default.
• W2980572009 cites W1983591607 @default.
• W2980572009 cites W1988345297 @default.
• W2980572009 cites W1988931744 @default.
• W2980572009 cites W1991982084 @default.
• W2980572009 cites W1992858430 @default.
• W2980572009 cites W1994074679 @default.
• W2980572009 cites W1994585625 @default.
• W2980572009 cites W1996392174 @default.
• W2980572009 cites W1996598168 @default.
• W2980572009 cites W1997702790 @default.
• W2980572009 cites W1999665440 @default.
• W2980572009 cites W2000146539 @default.
• W2980572009 cites W2000147802 @default.
• W2980572009 cites W2001450061 @default.
• W2980572009 cites W2003081312 @default.
• W2980572009 cites W2005587919 @default.
• W2980572009 cites W2006656714 @default.
• W2980572009 cites W2008931469 @default.
• W2980572009 cites W2008955505 @default.
• W2980572009 cites W2009608314 @default.
• W2980572009 cites W2012513486 @default.
• W2980572009 cites W2013167752 @default.
• W2980572009 cites W2013629548 @default.
• W2980572009 cites W2014448032 @default.
• W2980572009 cites W2015245464 @default.
• W2980572009 cites W2016186233 @default.
• W2980572009 cites W2017578953 @default.
• W2980572009 cites W2018027481 @default.
• W2980572009 cites W2020307057 @default.
• W2980572009 cites W2020635056 @default.
• W2980572009 cites W2022267899 @default.
• W2980572009 cites W2022383841 @default.
• W2980572009 cites W2023671946 @default.
• W2980572009 cites W2027681557 @default.
• W2980572009 cites W2029326259 @default.
• W2980572009 cites W2030239113 @default.
• W2980572009 cites W2031113117 @default.
• W2980572009 cites W2033226187 @default.
• W2980572009 cites W2033863659 @default.
• W2980572009 cites W2036238692 @default.
• W2980572009 cites W2036322615 @default.
• W2980572009 cites W2036756193 @default.
• W2980572009 cites W2036941879 @default.
• W2980572009 cites W2038484883 @default.
• W2980572009 cites W2039930386 @default.
• W2980572009 cites W2039983513 @default.
• W2980572009 cites W2045716315 @default.
• W2980572009 cites W2045832416 @default.
• W2980572009 cites W2047028663 @default.
• W2980572009 cites W2049070044 @default.
• W2980572009 cites W2051020143 @default.
• W2980572009 cites W2051163942 @default.
• W2980572009 cites W2055894313 @default.
• W2980572009 cites W2057541068 @default.
• W2980572009 cites W2061025681 @default.
• W2980572009 cites W2063275861 @default.
• W2980572009 cites W2068712706 @default.
• W2980572009 cites W2069400651 @default.
• W2980572009 cites W2071596004 @default.
• W2980572009 cites W2071945573 @default.
• W2980572009 cites W2072223647 @default.
• W2980572009 cites W2073959308 @default.
• W2980572009 cites W2074132546 @default.
• W2980572009 cites W2080279782 @default.
• W2980572009 cites W2080322412 @default.
• W2980572009 cites W2083556008 @default.
• W2980572009 cites W2083964776 @default.
• W2980572009 cites W2085274497 @default.
• W2980572009 cites W2086234584 @default.
• W2980572009 cites W2088576983 @default.
• W2980572009 cites W2089077776 @default.
• W2980572009 cites W2090322217 @default.
• W2980572009 cites W2097502628 @default.
• W2980572009 cites W2097901958 @default.
• W2980572009 cites W2098276532 @default.
• W2980572009 cites W2098968578 @default.
• W2980572009 cites W2100810082 @default.

• next